Your browser doesn't support javascript.
loading
Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory.
Donker, Albertine E; Schaap, Charlotte C M; Novotny, Vera M J; Smeets, Roel; Peters, Tessa M A; van den Heuvel, Bert L P; Raphael, Martine F; Rijneveld, Anita W; Appel, Inge M; Vlot, Andre J; Versluijs, A Birgitta; van Gelder, Michel; Granzen, Bernd; Janssen, Mirian C H; Rennings, Alexander J M; van de Veerdonk, Frank L; Brons, Paul P T; Bakkeren, Dirk L; Nijziel, Marten R; Vlasveld, L Thom; Swinkels, Dorine W.
Afiliación
  • Donker AE; Radboudumc Expert Center for Iron Disorders, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Schaap CC; Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Novotny VM; Radboudumc Expert Center for Iron Disorders, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Smeets R; Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Peters TM; Radboudumc Expert Center for Iron Disorders, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van den Heuvel BL; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Raphael MF; Radboudumc Expert Center for Iron Disorders, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Rijneveld AW; Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Appel IM; Radboudumc Expert Center for Iron Disorders, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Vlot AJ; Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Versluijs AB; Radboudumc Expert Center for Iron Disorders, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Gelder M; Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Granzen B; Department of Pediatric Hematology, University Medical Center, Utrecht, The Netherlands.
  • Janssen MC; Department of Hematology, Erasmus MC, Rotterdam, The Netherlands.
  • Rennings AJ; Department of Pediatric Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands.
  • van de Veerdonk FL; Department of Internal Medicine, Rijnstate Hospital Arnhem, Arnhem, The Netherlands.
  • Brons PP; Department of Pediatric Hematology, University Medical Center, Utrecht, The Netherlands.
  • Bakkeren DL; Department of Hematology, Maastricht UMC, The Netherlands.
  • Nijziel MR; Department of Pediatrics, Maastricht UMC, Maastricht, The Netherlands.
  • Vlasveld LT; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Swinkels DW; Radboudumc Expert Center for Iron Disorders, Radboud University Medical Center, Nijmegen, The Netherlands.
Am J Hematol ; 91(12): E482-E490, 2016 12.
Article en En | MEDLINE | ID: mdl-27643674
TMPRSS6 variants that affect protein function result in impaired matriptase-2 function and consequently uninhibited hepcidin production, leading to iron refractory iron deficiency anemia (IRIDA). This disease is characterized by microcytic, hypochromic anemia and serum hepcidin values that are inappropriately high for body iron levels. Much is still unknown about its pathophysiology, genotype-phenotype correlation, and optimal clinical management. We describe 14 different TMPRSS6 variants, of which 9 are novel, in 21 phenotypically affected IRIDA patients from 20 families living in the Netherlands; 16 out of 21 patients were female. In 7 out of 21 cases DNA sequencing and multiplex ligation dependent probe amplification demonstrated only heterozygous TMPRSS6 variants. The age at presentation, disease severity, and response to iron supplementation were highly variable, even for patients and relatives with similar TMPRSS6 genotypes. Mono-allelic IRIDA patients had a milder phenotype with respect to hemoglobin and MCV and presented significantly later in life with anemia than bi-allelic patients. Transferrin saturation (TSAT)/hepcidin ratios were lower in IRIDA probands than in healthy relatives. Most patients required parenteral iron. Genotype alone was not predictive for the response to oral iron. We conclude that IRIDA is a genotypically and phenotypically heterogeneous disease. The high proportion of female patients and the discrepancy between phenotypes of probands and relatives with the same genotype, suggest a complex interplay between genetic and acquired factors in the pathogenesis of IRIDA. In the absence of inflammation, the TSAT/hepcidin ratio is a promising diagnostic tool, even after iron supplementation has been given. Am. J. Hematol. 91:E482-E490, 2016. © 2016 Wiley Periodicals, Inc.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anemia Ferropénica Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País/Región como asunto: Europa Idioma: En Revista: Am J Hematol Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anemia Ferropénica Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País/Región como asunto: Europa Idioma: En Revista: Am J Hematol Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos